Sector footprint
$224.3M in exports
Reported chemicals exports in 2024 across 83 qualifying HS6 products.
Sector export playbook ยท HS 28-38
Explore Equatorial Guinea's HS 28-38 product portfolio, buyer markets, growth signals, and diversification opportunities. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Chemicals capability
Compare exporter scale with product breadth, buyer demand, growth, and destination reach. A large sector does not remove the need for product, compliance, pricing, and buyer validation.
Sector footprint
Reported chemicals exports in 2024 across 83 qualifying HS6 products.
Global demand
The sector's reported buyer import base provides context for product and market prioritization.
How to use the guide
Start with products that combine demand and exporter capability, then validate standards, route economics, buyers, and competition.
Product portfolio
Each HS6 product is ranked by calculated opportunity and shown with reported market size, exporter exports, growth, and destination reach.
| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
|---|---|---|---|---|---|---|
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $13.4B | $99.4K | $5.6B | +14.8% | 4 | +0.0% |
| HS 290110Acyclic hydrocarbons: saturated | $1.1B | $172.9K | $1.5B | +14.1% | 2 | +0.0% |
| HS 290511Alcohols: saturated monohydric, methanol (methyl alcohol) | $3.8B | $220.2M | $1.5B | +25.1% | 10 | +5.9% |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $2.4B | $1.0K | $1.2B | +15.1% | 3 | +0.0% |
| HS 382499Chemical products, mixtures and preparations: n.e.c. heading 3824 | $1.6B | $1.5K | $1.1B | -52.7% | 2 | +0.0% |
| HS 293379Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | $1.3B | $1.5M | $751.0M | +27.0% | 1 | +0.1% |
| HS 293329Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives | $201.4M | $99.3K | $178.1M | -4.1% | 1 | +0.0% |
| HS 293339Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $238.8M | $65.0K | $163.0M | +0.5% | 1 | +0.0% |
| HS 293349Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts | $135.9M | $11.6K | $151.9M | -5.4% | 1 | +0.0% |
| HS 293359Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $375.3M | $155.7K | $126.4M | +3.9% | 1 | +0.0% |
| HS 293331Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, pyridine and its salts | $67.8M | $27.9K | $93.1M | +6.3% | 1 | +0.0% |
| HS 290220Cyclic hydrocarbons: benzene | $154.8M | $46.8K | $88.7M | +4.8% | 1 | +0.0% |
| HS 293499Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $392.4M | $193.0K | $84.7M | -2.8% | 1 | +0.0% |
| HS 290321Unsaturated chlorinated derivatives of acyclic hydrocarbons: vinyl chloride (chloroethylene) | $78.2M | $818.9 | $84.4M | -10.9% | 1 | +0.0% |
| HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $244.3M | $76.3 | $80.9M | -10.4% | 1 | +0.0% |
| HS 291736Acids: aromatic polycarboxylic acids: terephthalic acid and its salts | $80.6M | $53.5K | $77.3M | +2.7% | 1 | +0.1% |
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $113.3M | $96.7K | $69.3M | +65.3% | 1 | +0.1% |
| HS 290339Fluorinated, brominated or iodinated derivatives of acyclic hydrocarbons: other than ethylene dibromide (ISO) (1,2-dibromoethane) | $160.2M | $59.2K | $68.3M | +4.1% | 1 | +0.0% |
| HS 340319Lubricating preparations: (other than for the treatment of textile and similar materials), containing less than 70% (by weight) of petroleum oils or oils obtained from bituminous minerals | $141.0M | $225.1 | $68.0M | +33.3% | 1 | +0.0% |
| HS 292429Cyclic amides (including cyclic carbamates) and their derivatives: other than the derivatives and salts of ureines, 2-acetamidobenzoic acid (N-acetylanthancillic acid), and ethinamate S | $124.5M | $76.9K | $65.3M | +1.9% | 1 | +0.1% |
| HS 340399Lubricating preparations: other than for the treatment of textile and similar materials, not containing petroleum oils or oils obtained from bituminous minerals | $204.7M | $757.6 | $63.6M | +11.1% | 2 | +0.0% |
| HS 293399Heterocyclic compounds: n.e.c. in headings no. 2933 | $185.4M | $258.3K | $62.4M | +2.3% | 1 | +0.1% |
| HS 294110Antibiotics: penicillins and their derivatives with a penicillanic acid structure: salts thereof | $85.8M | $31.5K | $57.1M | +0.0% | 1 | +0.0% |
| HS 300190Glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 | $205.3M | $76.6 | $53.9M | -21.8% | 1 | +0.0% |
| HS 321410Mastics: painters' fillings | $89.3M | $233.2 | $52.4M | +3.9% | 1 | +0.0% |
| HS 290531Alcohols: acyclic, diols: ethylene glycol (ethanediol) | $57.0M | $19.5K | $51.1M | -2.5% | 1 | +0.0% |
| HS 340120Soap: in forms n.e.c. in item no. 3401.11 | $33.8M | $4.6K | $44.2M | +186.0% | 1 | +0.1% |
| HS 291899Acids: carboxylic acids, with additional oxygen function (not alcohol, phenol, aldehyde or ketone) and their anhydrides, halides, peroxides and peroxyacids: their halogenated, sulphonated, nitrated or nitrosated derivatives: other than 2,4,5-T (ISO) | $55.2M | $29.2K | $43.5M | -0.4% | 1 | +0.1% |
| HS 320611Colouring matter: pigments and preparations based on titanium dioxide, containing 80% or more by weight of titanium dioxide calculated on the dry matter | $40.5M | $342.3 | $41.2M | -3.4% | 1 | +0.0% |
| HS 293722Steroidal hormones, their derivatives and structural analogues: halogenated derivatives of corticosteroidal hormones | $56.9M | $21.7K | $40.9M | +3.0% | 1 | +0.0% |
| HS 293719Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $51.1M | $63.5K | $40.6M | +14.3% | 1 | +0.1% |
| HS 293979Alkaloids: of vegetal origin, other than cocaine, ecgonine: salts, esters and other derivatives: n.e.c. in heading no. 2939 | $49.0M | $12.3K | $34.9M | +16.5% | 1 | +0.0% |
| HS 293090Organo-sulphur compounds: n.e.s. in heading no. 2930 | $83.9M | $32.4K | $34.3M | +24.6% | 1 | +0.0% |
| HS 290545Alcohols: polyhydric, glycerol | $64.5M | $44.2K | $33.1M | +3.3% | 1 | +0.1% |
| HS 294190Antibiotics: n.e.c. in heading no. 2941 | $100.8M | $75.2K | $30.7M | -4.4% | 1 | +0.1% |
| HS 293220Heterocyclic compounds: with oxygen hetero-atom(s) only, containing an unfused furan ring (whether or not hydrogenated) in the structure, lactones | $76.7M | $25.5K | $29.7M | -11.6% | 1 | +0.0% |
| HS 292610Nitrile-function compounds: acrylonitrile | $51.1M | $13.2K | $29.5M | -1.3% | 1 | +0.0% |
| HS 292249Amino-acids, other than those containing more than one kind of oxygen function, their esters: salts thereof, excluding lysine, glutamic acid, anthranalic acid and tilidine, their esters and salts thereof | $70.8M | $36.4K | $27.7M | -0.1% | 1 | +0.1% |
| HS 292529Imines and their derivatives: salts thereof: other than chlordimeform (ISO) | $46.7M | $20.8K | $27.6M | +6.6% | 1 | +0.0% |
| HS 293134Organo-inorganic compounds: organo-phosphorus derivatives, sodium-3-(hydroxysilyl)propyl methylphosphonate | $28.1M | $14.6K | $27.4M | +5.3% | 1 | +0.1% |
| HS 291612Acids: unsaturated acyclic monocarboxylic acids: esters of acrylic acid | $80.7M | $37.4K | $26.3M | -2.4% | 1 | +0.0% |
| HS 291590Acids: saturated acyclic monocarboxylic acids: anhydrides, halides, peroxides, peroxyacids and halogenated, sulphonated, nitrated or nitrosated derivatives, n.e.c. in heading no. 2915 | $113.5M | $39.6K | $24.1M | -3.3% | 1 | +0.0% |
| HS 293190Organo-inorganic compounds: other than tetramethyl lead, tetraethyl lead, and tributyltin compounds | $64.7M | $29.8K | $24.1M | +8.6% | 1 | +0.0% |
| HS 293214Heterocyclic compounds: with oxygen hetero-atom(s) only, containing an unfused furan ring (whether or not hydrogenated) in the structure, sucralose | $20.8M | $14.3K | $23.9M | +0.9% | 1 | +0.1% |
| HS 292320Lecithins and other phosphoaminolipids, whether or not chemically defined | $50.2M | $17.1K | $23.9M | +3.2% | 1 | +0.0% |
| HS 290712Monophenols: cresols and their salts | $33.3M | $15.1K | $23.6M | -1.2% | 1 | +0.0% |
| HS 292241Amino-acids: their esters, (other than those containing more than one kind of oxygen function), lysine and its esters: salts thereof | $57.5M | $19.6K | $23.2M | +2.2% | 1 | +0.0% |
| HS 380891Insecticides: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $31.8M | $2.1K | $23.2M | +3.8% | 1 | +0.0% |
| HS 292419Acyclic amides (including acyclic carbamates) and their derivatives: salts thereof, other than meprobamate (INN), fluoroacetamide (ISO), monocrotophos (ISO) or phosphamidon (ISO) | $74.3M | $36.8K | $23.1M | +5.7% | 1 | +0.0% |
| HS 291733Acids: aromatic polycarboxylic acids: dinonyl or didecyl orthophthalates | $29.4M | $14.6K | $22.9M | +6.0% | 1 | +0.0% |
| HS 291422Ketones: cyclanic, cyclenic or cycloterpenic, without other oxygen function, cyclohexanone and methylcyclohexanones | $37.8M | $4.8K | $22.7M | +2.7% | 1 | +0.0% |
| HS 293911Alkaloids, vegetable: of opium and their derivatives: salts thereof | $41.9M | $11.5K | $21.7M | +2.0% | 1 | +0.0% |
| HS 293299Heterocyclic compounds: with oxygen hetero-atom(s) only, no lactones or unfused furan rings (hydrogenated or not) in the structure, other than isosafrole, 1-(1,3-benzodiaxol-5-yl) propan-2-one, piperonal, safrole, tetrahydrocannabinols (all isomers) | $69.2M | $27.2K | $21.5M | -3.8% | 1 | +0.0% |
| HS 291814Acids: carboxylic acids, (with alcohol function but without other oxygen function), citric acid | $49.4M | $20.4K | $21.3M | +1.5% | 1 | +0.0% |
| HS 292219Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters: salts thereof, n.e.c. in item no. 2922.1 | $45.1M | $23.5K | $20.4M | -2.1% | 1 | +0.1% |
| HS 290949Ether-alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives: n.e.s. in item no. 2909.4 | $73.1M | $32.2K | $19.7M | -0.6% | 1 | +0.0% |
| HS 290519Alcohols: saturated monohydric, n.e.s. in item no. 2905.1 | $26.7M | $5.9K | $19.5M | -3.5% | 1 | +0.0% |
| HS 290711Monophenols: phenol (hydroxybenzene) and its salts | $45.3M | $15.1K | $18.9M | -4.5% | 1 | +0.0% |
| HS 292090Esters of inorganic acids (excluding esters of hydrogen halides) and their salts, their halogenated, sulphonated, nitrated or nitrosated derivatives, n.e.s. in heading no. 2920 | $41.3M | $20.3K | $18.9M | +5.9% | 1 | +0.0% |
| HS 293040Organo-sulphur compounds: methionine | $34.6M | $3.9K | $18.7M | +6.9% | 1 | +0.0% |
| HS 290129Acyclic hydrocarbons: unsaturated, n.e.s. in heading no. 2901 | $34.9M | $10.4K | $18.2M | -0.4% | 1 | +0.0% |
| HS 290919Ethers: acyclic, and their halogenated, sulphonated, nitrated or nitrosated derivatives, other than diethyl ether | $29.3M | $15.3K | $17.9M | -5.5% | 1 | +0.1% |
| HS 291532Acids: saturated acyclic monocarboxylic acids: vinyl acetate | $39.8M | $14.2K | $17.8M | +0.4% | 1 | +0.0% |
| HS 291479Ketones and quinones: halogenated, sulphonated, nitrated or nitrosated derivatives, other than chlordecone (ISO) | $26.0M | $18.8K | $17.8M | +8.4% | 1 | +0.1% |
| HS 290331Fluorinated, brominated or iodinated derivatives of acyclic hydrocarbons: ethylene dibromide (ISO) (1,2-dibromoethane) | $16.3M | $6.6K | $17.3M | -5.4% | 1 | +0.0% |
| HS 290532Alcohols: acyclic, diols: propylene glycol (propane-1, 2-diol) | $39.4M | $23.5K | $17.2M | -1.2% | 1 | +0.1% |
| HS 292250Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function | $56.7M | $84.2K | $16.8M | -3.6% | 1 | +0.1% |
| HS 290311Saturated chlorinated derivatives of acyclic hydrocarbons: chloromethane (methyl chloride) and chloroethane (ethyl chloride) | $15.9M | $7.6K | $16.5M | +0.3% | 1 | +0.0% |
| HS 291819Acids: carboxylic acids, (with alcohol function but without other oxygen function), other than lactic, tartaric, citric, and gluconic acids and their salts and esters | $44.7M | $17.0K | $16.3M | +3.5% | 1 | +0.0% |
| HS 292390Quaternary ammonium salts and hydroxides: whether or not chemically defined n.e.c. in heading no. 2923 | $42.2M | $16.7K | $16.2M | +4.2% | 1 | +0.0% |
| HS 290250Cyclic hydrocarbons: styrene | $30.0M | $17.2K | $15.9M | -8.7% | 1 | +0.1% |
| HS 290122Acyclic hydrocarbons: unsaturated, propene (propylene) | $39.4M | $15.2K | $15.6M | -2.9% | 1 | +0.0% |
| HS 291611Acids: unsaturated acyclic monocarboxylic acids: acrylic acid and its salts | $25.6M | $13.3K | $15.6M | -5.0% | 1 | +0.1% |
| HS 290543Alcohols: polyhydric, mannitol | $14.3M | $5.1K | $15.4M | +17.3% | 1 | +0.0% |
| HS 292910Nitrogen-function compounds: n.e.c. in chapter 29, isocyanates | $50.7M | $25.9K | $15.1M | -4.3% | 1 | +0.1% |
| HS 293627Vitamins: vitamin C and its derivatives, unmixed | $39.6M | $11.8K | $14.5M | -2.2% | 1 | +0.0% |
| HS 290542Alcohols: polyhydric, pentaerythritol | $16.4M | $5.8K | $14.4M | +5.9% | 1 | +0.0% |
| HS 293629Vitamins: n.e.c. in item no. 2936.2, and their derivatives, unmixed | $43.6M | $17.4K | $14.0M | -1.5% | 1 | +0.0% |
| HS 294000Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose: sugar ethers, sugar acetals and sugar esters, and their salts, other than the products of heading 29.37, 29.38, or 29.39 | $30.8M | $17.5K | $13.9M | +0.3% | 1 | +0.1% |
| HS 293628Vitamins: vitamin E and its derivatives, unmixed | $43.6M | $12.3K | $13.8M | -3.1% | 1 | +0.0% |
| HS 291411Ketones: acyclic, without other oxygen function, acetone | $22.2M | $1.7K | $13.5M | -12.1% | 1 | +0.0% |
| HS 293890Glycosides: natural or reproduced by synthesis, other than rutoside (rutin) and its derivatives | $26.5M | $12.4K | $13.4M | +2.8% | 1 | +0.0% |
| HS 293361Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, melamine | $26.3M | $10.0K | $13.2M | +0.1% | 1 | +0.0% |
Best markets
Markets are ranked by calculated opportunity across the qualifying products in this sector view.
CHN
1 products represented in the sector.
$4.1B$9.7B reported buyer importsGBR
71 products represented in the sector.
$3.7B$6.5B reported buyer importsFRA
4 products represented in the sector.
$2.3B$5.3B reported buyer importsUSA
2 products represented in the sector.
$1.4B$1.3B reported buyer importsCAN
2 products represented in the sector.
$1.1B$1.5B reported buyer importsNLD
3 products represented in the sector.
$409.8M$1.1B reported buyer importsDEU
1 products represented in the sector.
$245.6M$664.0M reported buyer importsBEL
1 products represented in the sector.
$228.8M$418.5M reported buyer importsESP
4 products represented in the sector.
$210.4M$731.9M reported buyer importsBRA
1 products represented in the sector.
$208.5M$614.4M reported buyer importsCZE
1 products represented in the sector.
$177.0M$707.3M reported buyer importsZAF
1 products represented in the sector.
$166.7M$338.9M reported buyer importsGrowth stars
Average product-level CAGR is a screening signal. Confirm the latest trend, base effects, buyer quality, and commercial feasibility before acting.
| Product | Average CAGR | Opportunity | Markets |
|---|---|---|---|
| HS 340120Soap: in forms n.e.c. in item no. 3401.11 | +186.0% | $44.2M | 1 |
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | +65.3% | $69.3M | 1 |
| HS 340319Lubricating preparations: (other than for the treatment of textile and similar materials), containing less than 70% (by weight) of petroleum oils or oils obtained from bituminous minerals | +33.3% | $68.0M | 1 |
| HS 293379Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | +27.0% | $751.0M | 1 |
| HS 290511Alcohols: saturated monohydric, methanol (methyl alcohol) | +25.1% | $1.5B | 10 |
| HS 293090Organo-sulphur compounds: n.e.s. in heading no. 2930 | +24.6% | $34.3M | 1 |
| HS 290543Alcohols: polyhydric, mannitol | +17.3% | $15.4M | 1 |
| HS 293979Alkaloids: of vegetal origin, other than cocaine, ecgonine: salts, esters and other derivatives: n.e.c. in heading no. 2939 | +16.5% | $34.9M | 1 |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | +15.1% | $1.2B | 3 |
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | +14.8% | $5.6B | 4 |
Diversification opportunities
Destination count is a simple breadth indicator. It does not measure destination concentration or guarantee resilience.
HS 290511
HS 330499
HS 382200
HS 290110
HS 382499
HS 340399
HS 293379
HS 293329
Frequently asked questions
Practical guidance for interpreting sector scale, growth, product breadth, and buyer markets.
Compare sector exports, product breadth, buyer markets, growth, and global demand. These signals identify research priorities rather than guarantee market access.
Products with higher average reported growth in the screened rows. Validate the time period, base effects, buyer demand, and current exporter position.
Products reaching more buyer markets in the screened data. Destination breadth is useful context but does not replace concentration, route, or buyer analysis.
Data source
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.